These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25623883)

  • 21. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
    Dans AM; Villarruz MV; Jimeno CA; Javelosa MA; Chua J; Bautista R; Velez GG
    J Clin Epidemiol; 2007 Jun; 60(6):554-9. PubMed ID: 17493509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial.
    Tan M; Johns D; González Gálvez G; Antúnez O; Fabián G; Flores-Lozano F; Zúñiga Guajardo S; Garza E; Morales H; Konkoy C; Herz M;
    Clin Ther; 2004 May; 26(5):680-93. PubMed ID: 15220012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does bromocriptine improve glycemic control of obese type-2 diabetics?
    Aminorroaya A; Janghorbani M; Ramezani M; Haghighi S; Amini M
    Horm Res; 2004; 62(2):55-9. PubMed ID: 15205563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of glibenclamide on blood pressure and cardiovascular responsiveness in non-insulin dependent diabetes mellitus.
    Williams S; Abbott D; Morfis L; Manwaring P; Diamond T; Howes LG
    J Hypertens; 1998 May; 16(5):705-11. PubMed ID: 9797183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liraglutide in diabetes mellitus: More facts and findings.
    Rahman IU; Idrees M; Bashir M; Khan MI; Jan NU; Rahim H
    Pak J Pharm Sci; 2016 Mar; 29(2):609-13. PubMed ID: 27087083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.
    Kosegawa I; Chen S; Awata T; Negishi K; Katayama S
    Clin Exp Hypertens; 1999 Apr; 21(3):199-211. PubMed ID: 10225476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of two different glibenclamide dose-strengths in the fixed combination with metformin in patients with poorly controlled T2DM: a double blind, prospective, randomised, cross-over clinical trial.
    Brunetti P; Pagano G; Turco C; Gori M; Perriello G;
    Diabetes Nutr Metab; 2004 Dec; 17(6):350-7. PubMed ID: 15887629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
    Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
    Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A double blind randomized placebo controlled clinical trial.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    Phytomedicine; 2021 Jan; 81():153431. PubMed ID: 33352495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
    Marre M; Howlett H; Lehert P; Allavoine T
    Diabet Med; 2002 Aug; 19(8):673-80. PubMed ID: 12147149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes.
    Hussain SA
    J Med Food; 2007 Sep; 10(3):543-7. PubMed ID: 17887949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
    Miyazaki Y; Mahankali A; Matsuda M; Glass L; Mahankali S; Ferrannini E; Cusi K; Mandarino LJ; DeFronzo RA
    Diabetes Care; 2001 Apr; 24(4):710-9. PubMed ID: 11315836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus.
    Konya H; Hasegawa Y; Hamaguchi T; Satani K; Umehara A; Katsuno T; Ishikawa T; Miuchi M; Kohri K; Suehiro A; Kakishita E; Miyagawa J; Namba M
    Metabolism; 2010 Sep; 59(9):1294-9. PubMed ID: 20070990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.
    Grant SJ; Chang DH; Liu J; Wong V; Kiat H; Bensoussan A
    BMC Complement Altern Med; 2013 May; 13():104. PubMed ID: 23672597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients.
    Johnston PS; Lebovitz HE; Coniff RF; Simonson DC; Raskin P; Munera CL
    J Clin Endocrinol Metab; 1998 May; 83(5):1515-22. PubMed ID: 9589648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
    Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
    Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice.
    Dwijayanti DR; Shimada T; Ishii T; Okuyama T; Ikeya Y; Mukai E; Nishizawa M
    Phytother Res; 2020 Jun; 34(6):1338-1346. PubMed ID: 31845444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up.
    Alvarsson M; Sundkvist G; Lager I; Berntorp K; Fernqvist-Forbes E; Steen L; Orn T; Holberg MA; Kirksaether N; Grill V
    Diabetes Obes Metab; 2008 May; 10(5):421-9. PubMed ID: 17394534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.